Metabolic Score for Insulin Resistance Is Inversely Related to Incident Advanced Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease

Metabolic Score for Insulin Resistance Is Inversely Related to Incident Advanced Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease

We determined the relationships between metabolic score for IR (METS-IR), triglyceride-glucose (TyG) index, and homeostatic model assessment for IR (HOMA-IR) and incident advanced liver fibrosis (ALF) and assessed the abilities of the three IR indicators to predict ALF in patients with non-alcoholic...

Full description

Bibliographic Details
Main Authors:	Jun-Hyuk Lee, Yu-Jin Kwon, Kyongmin Park, Hye Sun Lee, Hoon-Ki Park, Jee Hye Han, Sang Bong Ahn
Format:	Article
Language:	English
Published:	MDPI AG 2022-07-01
Series:	Nutrients
Subjects:	liver fibrosis insulin resistance incidence Korean non-alcoholic fatty liver disease
Online Access:	https://www.mdpi.com/2072-6643/14/15/3039

Similar Items

Correspondence on Letter regarding “The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults”
by: Jun-Hyuk Lee, et al.
Published: (2023-01-01)

Neck Circumference as a Predictor of Insulin Resistance in People with Non-alcoholic Fatty Liver Disease
by: Da-Hye Son, et al.
Published: (2023-09-01)

Correspondence on Editorial regarding “Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: Potential benefits and limitations”
by: Jun-Hyuk Lee, et al.
Published: (2023-01-01)

Different Associations of Coffee Consumption with the Risk of Incident Metabolic Dysfunction-Associated Steatotic Liver Disease and Advanced Liver Fibrosis
by: Jun-Hyuk Lee, et al.
Published: (2023-12-01)

Letter regarding “The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults”
by: Hye Won Lee
Published: (2023-01-01)

Changes in Insulin Resistance Index and the Risk of Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease without Diabetes: Kangbuk Samsung Health Study
by: Dae-Jeong Koo, et al.
Published: (2021-10-01)

Fatty Liver Is an Independent Risk Factor for Elevated Intraocular Pressure
by: Jun-Hyuk Lee, et al.
Published: (2022-10-01)

Insulin resistance, atherogenic disorders and liver fibrosis in patients with metabolic syndrome
Published: (2014-06-01)

NONALCOHOLIC FATTY LIVER DISEASE: COMORBIDITIES, CLINICAL SIGNIFICANCE AND EVALUATION OF LIVER FIBROSIS
by: D. V. Marshalko, et al.
Published: (2018-02-01)

The Progression of Liver Fibrosis in Non-alcoholic Fatty Liver Disease
by: Moon Young Kim
Published: (2017-06-01)

Liver Stiffness-Based Risk Prediction Model for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease
by: Jae Seung Lee, et al.
Published: (2021-09-01)

Liver fibrosis is a common pathological change in the liver of dairy cows with fatty liver
by: Cai Zhang, et al.
Published: (2023-04-01)

Liver biopsy in the quantitative assessment of liver fibrosis in nonalcoholic fatty liver disease
by: Gwyneth Shook Ting Soon, et al.
Published: (2021-01-01)

Expression of the Long Noncoding RNA GAS5 Correlates with Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
by: Man-Hoon Han, et al.
Published: (2020-05-01)

Relationship between Insulin Resistance Risk Scales and Non-Alcoholic Fatty Liver Disease and Liver Fibrosis Scales in 219,477 Spanish Workers
by: José Ignacio Ramírez-Manent, et al.
Published: (2022-11-01)

Liver Fibrosis, Liver Cancer, and Advances in Therapeutic Approaches
by: Indu Rajapaksha
Published: (2022-11-01)

A review of liver fibrosis and cirrhosis regression
by: Michael J. Lee
Published: (2023-07-01)

The FINDRISC scale as a risk assessment tool for liver fibrosis in patients with nonalcoholic fatty liver disease
by: A. S. Kuznetsova, et al.
Published: (2023-01-01)

Clinical Application of Non-invasive Diagnostic Tests for Liver Fibrosis
by: Jung Woo Shin, et al.
Published: (2016-07-01)

Changed Amino Acids in NAFLD and Liver Fibrosis: A Large Cross-Sectional Study without Influence of Insulin Resistance
by: Takuma Hasegawa, et al.
Published: (2020-05-01)

Noninvasive diagnosis of liver fibrosis in patients with nonalcoholic fatty liver disease
by: Yu.M. Stepanov, et al.
Published: (2017-09-01)

Noninvasive imaging biomarkers for liver fibrosis in nonalcoholic fatty liver disease: current and future
by: Jung Hwan Yu, et al.
Published: (2023-02-01)

Chronic Alcohol Consumption is Inversely Associated with Insulin Resistance and Fatty Liver in Japanese Males
by: Takemi Akahane, et al.
Published: (2020-04-01)

Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment
by: Leen J. M. Heyens, et al.
Published: (2021-04-01)

Improving detection of cystic fibrosis related liver disease using liver fibrosis assessment tools
by: Jennifer A. Scott, et al.
Published: (2023-11-01)

Ectopic Liver Tissue Formation in Rats with Induced Liver Fibrosis
by: Bauyrzhan Umbayev, et al.
Published: (2014-12-01)

A Noninvasive Scoring System for Liver Fibrosis in Patients With Metabolic Dysfunction-Associated Fatty Liver Disease
by: Moniyka Sachar, et al.
Published: (2022-01-01)

Cystic fibrosis related liver disease and endocrine considerations
by: Jordan S. Sherwood, et al.
Published: (2022-03-01)

Metabolic Syndrome Is Associated With Advanced Liver Fibrosis Among Pediatric Patients With Non-alcoholic Fatty Liver Disease
by: Yi-Wen Ting, et al.
Published: (2019-11-01)

Liver stiffness and liver function index in liver fibrosis patients afflicted with electrocardiographic abnormalities
by: Eskandar Hajiani, et al.
Published: (2022-01-01)

Hyperuricemia Is Associated with Significant Liver Fibrosis in Subjects with Nonalcoholic Fatty Liver Disease, but Not in Subjects without It
by: Pei-Chia Yen, et al.
Published: (2022-03-01)

STAT3 Decoy Oligodeoxynucleotides Suppress Liver Inflammation and Fibrosis in Liver Cancer Cells and a DDC-Induced Liver Injury Mouse Model
by: Hye Jin Choi, et al.
Published: (2024-01-01)

Formyl Peptide Receptor 2 Alleviates Hepatic Fibrosis in Liver Cirrhosis by Vascular Remodeling
by: Ji Hye Jun, et al.
Published: (2021-02-01)

Reversal of liver fibrosis
by: Ismail Mona, et al.
Published: (2009-01-01)

The Impact of Insulin Resistance on Hepatic Fibrosis among United States Adults with Non-Alcoholic Fatty Liver Disease: NHANES 2017 to 2018
by: Ji Cheol Bae, et al.
Published: (2022-06-01)

Association between Growth Hormone and Insulin-like Growth Factor-1 (IGF-1) Levels, Liver Function and Short-Term Survival of Paediatric Liver Recipients
by: R. M. Kurabekova, et al.
Published: (2020-09-01)

The roles and mechanisms of hypoxia in liver fibrosis
by: Jingyao Cai, et al.
Published: (2021-05-01)

Liver Fibrosis: Current Principles of Diagnosis
by: A.K. Duda, et al.
Published: (2014-09-01)

Liver fibrosis in children: a comprehensive review of mechanisms, diagnosis, and therapy
by: Elif Ozdogan, et al.
Published: (2023-03-01)

Liver Cirrhosis Patients Who Had Normal Liver Function Before Liver Cirrhosis Development Have the Altered Metabolic Profiles Before the Disease Occurrence Compared to Healthy Controls
by: Hye Jin Yoo, et al.
Published: (2019-11-01)